Evidence map›Paper›PMID 42577669›Full record

ArticleCirculation reports2026

Methamphetamine-Associated Pulmonary Arterial Hypertension in a Japanese Pulmonary Hypertension Referral Center.

Shinya Fujisaki, Atsushi Kuraishi, Ryo Takano, Hiroya Hayashi, Ryotaro Asano, Takeshi Ogo

Abstract read
In one paragraph

Article in Circulation reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shinya FujisakiDivision of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center Osaka Japan.
Atsushi KuraishiDivision of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center Osaka Japan.
Ryo TakanoDivision of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center Osaka Japan.
Hiroya HayashiDivision of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center Osaka Japan.
Ryotaro AsanoDepartment of Vascular Physiology, National Cerebral and Cardiovascular Center Osaka Japan.
Takeshi OgoDivision of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center Osaka Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methamphetamine-associated pulmonary arterial hypertension (Meth-PAH) is increasingly recognized in Western countries, but Japanese data remain limited. Methods and Results: Of 363 patients with PAH, we identified 5 patients with Meth-PAH (1.4%); 4 were women, with a mean age of 37.6±7.2 years. Patients receiving PAH-specific therapy showed favorable hemodynamic responses, although 40% of patients experienced treatment discontinuation and methamphetamine reuse. Conclusions: In this case series of 5 Japanese patients with Meth-PAH, there was a high rate of treatment discontinuation and methamphetamine reuse, which suggests possible underdiagnosis of Meth-PAH and barriers to sustained care in Japan.

Indexed as

JapanMethamphetaminePulmonary arterial hypertension

Identifiers

PMID42577669
PMCPMC13454768

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.